DDOG vs DMAC · P/E 292, rev $3.43B vs $157.4M cap
Datadog Inc (DDOG) versus DiaMedica Therapeutics Inc (DMAC) — a side-by-side from cached financials, not a winner call.
Datadog Inc (DDOG) is a software - application company listed on US. It is led by Olivier Pomel.
DiaMedica Therapeutics Inc (DMAC) is a biotechnology company listed on US.
Latest reported DDOG revenue for 2025-12-31 was $3.43B. Net income was $107.7M. Revenue was up 27.7% from 2024-12-31 to 2025-12-31. DDOG currently screens at market cap $47.44B and trailing P/E 292.3.
DMAC does not have a complete income-statement cache yet.
DDOG currently screens at market cap $47.44B and trailing P/E 292.3. DMAC currently screens at market cap $157.4M.
Not investment advice. Open the DDOG and DMAC stock pages for the full models.
Not investment advice.